| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |